Skip to main content
. 2021 Apr 7;38(6):1323–1329. doi: 10.1007/s10815-021-02171-8

Table 1.

Baseline patient characteristics and IVM cycle outcome

Patient 1 Patient 2
Baseline patient characteristics*
Age (years) 25 30
BMI (kg/m2) 16.5 19.4
AMH (ng/mL) 24.5 12.3
AFC (N) 60 30
FSH (IU/L) <0.1 7.5
LH (IU/L) <0.1 8.8
Progesterone (nmol/L) 1.34 0.64
E2 (ng/L) 32.0 28.0
IVM cycle outcome Cycle 1 Cycle 2
COC retrieved (N) 70 77 30
MII oocytes (N) 35 37 25
2PN oocytes (N) 25 22 21
Cleavage-stage embryos (N) 17 7 20
Cryopreserved embryos (N/stage) 0 7 (d3) 7 (d5)
Fresh ET (N/stage) 1/BL4BB (d5) 0 1/BL4AA (d5)***
eFET (N/stage)** N/A 4 N/A
eFET no. 1 1/8c gr2 (d4)
eFET no. 2 1/C2 gr1 (d4)
eFET no. 3 1/5c gr3 (d4)
eFET no. 4 2/BL1 gr2, C2 gr2 (d4)***
Live birth 0 1 1

COC cumulus-oocyte complex, MII metaphase II, 2PN two pronuclei, ET embryo transfer, SET single embryo transfer, DET double embryo transfer, Y yes, N no

*Patient characteristics at intake (after unilateral oophorectomy)

**Cleavage-stage embryos were vitrified on day 3; embryo transfer was performed 1 day after embryo warming

***Resulting in live birth